摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-氟苯基)-1,4-二氢[1,3,5]三嗪并[1,2-a]苯并咪唑-2-胺 | 305852-99-7

中文名称
4-(4-氟苯基)-1,4-二氢[1,3,5]三嗪并[1,2-a]苯并咪唑-2-胺
中文别名
——
英文名称
4-(4-fluorophenyl)-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazole-2-amine
英文别名
2-amino-4-(4'-fluorophenyl)-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazole;4-(4-fluorophenyl)-4,10-dihydro-[1,3,5]triazino[1,2-a]benzimidazol-2-amine
4-(4-氟苯基)-1,4-二氢[1,3,5]三嗪并[1,2-a]苯并咪唑-2-胺化学式
CAS
305852-99-7
化学式
C15H12FN5
mdl
——
分子量
281.292
InChiKey
UMUNIZJNDXHOFR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    460.6±55.0 °C(Predicted)
  • 密度:
    1.52±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    68.2
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT

反应信息

  • 作为反应物:
    描述:
    4-(4-氟苯基)-1,4-二氢[1,3,5]三嗪并[1,2-a]苯并咪唑-2-胺盐酸 作用下, 以 乙醇 为溶剂, 反应 24.0h, 以0.28 g的产率得到2-amino-4-(4'-fluorophenyl)-4,10-dihydro[1,3,5]triazino[1,2-a]benzimidazole hydrochloride
    参考文献:
    名称:
    新型2-氨基-4-芳基-4,10-二氢[1,3,5]三嗪基[1,2-a]苯并咪唑的合成、晶体结构测定和抗增殖活性
    摘要:
    摘要 本手稿描述了新型 2-氨基-4-芳基-4,10-二氢-[1,3,5] 三嗪基[1,2-a]苯并咪唑盐酸盐 4a-n 和 5b 的合成2-胍基苯并咪唑与多功能杂芳醛之间的环缩合反应。已通过使用 1 H 和 13 C NMR、IR 和 UV/Vis 光谱研究了所有制备的化合物的结构。4f 的晶体和分子结构是通过单晶的 X 射线衍射确定的。2-氨基-4-(4'-甲基苯基)-4,10-二氢[1,3,5]三嗪基[1,2-a]苯并咪唑盐酸盐4f(C 16 H 16 N 5 + ·Cl - ) 以一种可能的互变异构形式以固态存在,在 1,4-二氢三嗪环的一个氮原子上被质子化。该分子在 4,10-二氢 [1,3,5] 三嗪基 [1, 2-a ]苯并咪唑部分与次甲基碳原子和 1,4-二氢三嗪环的质子化氮原子的平面偏差最大。阳离子通过 N–H⋯N 氢键连接成 R 2 2 (8) 中心对称二聚体。阳离子二聚体通过
    DOI:
    10.1016/j.molstruc.2011.10.054
  • 作为产物:
    描述:
    邻苯二胺 、 alkaline earth salt of/the/ methylsulfuric acid 在 哌啶 作用下, 以 乙醇 为溶剂, 反应 2.0h, 生成 4-(4-氟苯基)-1,4-二氢[1,3,5]三嗪并[1,2-a]苯并咪唑-2-胺
    参考文献:
    名称:
    Synthesis and biological activity of fluorinated 2-amino-4-aryl-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazoles
    摘要:
    The heterocyclic nucleus s-triazino[1,2-a]benzimidazole has been reported to exhibit antibacterial activity. In this study, seven new 3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazole derivatives were prepared via cyclocondensation between 2-guanidinobenzimidazole and fluorine substituted (including trifluoromethyl) benzaldehydes. The structures of all the compounds were confirmed by H-1, C-13 NMR and IR spectral data. Spectral data also suggested the existence of various tautomeric forms of the fluorine-containing s-triazino[1,2-a]benzimidazole compounds. The synthesized compounds were also screened for antibacterial and bovine dihydrofolate reductase (DHFR) inhibitory activities. The compound 3g substituted with a 3',5-bis(trifluoromethyl)phenyl moiety demonstrated the best antibacterial activity in the series. None of the tested compounds significantly inhibited bovine DHFR. (c) 2005 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.jfluchem.2005.02.009
点击查看最新优质反应信息

文献信息

  • Synthesis of ethyl 6-aryl-4-oxo-4,6-dihydro-1(12)(13)<i>h</i>-pyrimido-[2′,1′:4,5][1,3,5]triazino[1,2-<i>a</i>]benzimidazole-3-carboxylates
    作者:Anton V. Dolzhenko、Wai-Keung Chui、Anna V. Dolzhenko
    DOI:10.1002/jhet.5570430614
    日期:2006.11
    The synthesis of ethyl 6-aryl-4-oxo-4,6-dihdro-1(12)(13)H-pyrimido[2′,1′:4,5][1,3,5]triazino[1,2-a]-benzimidazole-3-carboxylates (4a-p) was described via pyrimidine ring annulation to 4-aryl-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazole-2-amines (2a-p) which were obtained from 2-guanidinobenzimidazole (1). Tautomerism in the prepared compounds was investigated using nmr spectroscopy. Compounds 2a-p
    乙基6-芳基-4-氧代-4,6-二氢-1(12)(13)H-嘧啶基[2',1':4,5] [1,3,5]三嗪[1, 2-一个] -苯并咪唑-3-羧酸盐(4A-p )中描述通过嘧啶环环至4-芳基-3,4-二氢[1,3,5]三嗪并[1,2一]苯并咪唑-2-由2-胍基苯并咪唑(1)获得的胺(2a-p)。使用核磁共振光谱研究了所制备化合物中的互变异构现象。发现化合物2a-p主要以3,4-二氢互变异构形式存在于二甲基亚砜溶液中。化合物4a-p以1-,12-和13 H的动态平衡存在-形式。发现4a-d的甲基化仅导致13-甲基取代的衍生物9a-d。
  • Three-component condensation of 4-aryl-1,4-dihydro-benzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-amines with formaldehyde and primary amines
    作者:A. Yu. Potapov、A. S. Shestakov、V. N. Verezhnikov、Kh. S. Shikhaliev
    DOI:10.1134/s1070428011070177
    日期:2011.7
    Three-component cyclization of 4-aryl-1,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-amines with formaldehyde and primary amines gave the corresponding 6-unsubstituted or 6-aryl-2-alkyl-2,3,4,6-tetrahydro-1H-[1,3,5]triazino[1′,2′:3,4][1,3,5]triazino[1,2-a]benzimidazoles.
    4-芳基-1,4-二氢苯并[4,5]咪唑并[1,2- a ] [1,3,5]三嗪-2-胺与甲醛和伯胺的三组分环化反应得到相应的6-未取代或6-芳基-2-烷基-2,3,4,6-四氢-1 H- [1,3,5] triazino [1',2':3,4] [1,3,5] triazino [ 1,2- α ]苯并咪唑。
  • Synthesis and biological activity of fluorinated 2-amino-4-aryl-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazoles
    作者:Anton V. Dolzhenko、Wai-Keung Chui、Anna V. Dolzhenko、Lai-Wah Chan
    DOI:10.1016/j.jfluchem.2005.02.009
    日期:2005.5
    The heterocyclic nucleus s-triazino[1,2-a]benzimidazole has been reported to exhibit antibacterial activity. In this study, seven new 3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazole derivatives were prepared via cyclocondensation between 2-guanidinobenzimidazole and fluorine substituted (including trifluoromethyl) benzaldehydes. The structures of all the compounds were confirmed by H-1, C-13 NMR and IR spectral data. Spectral data also suggested the existence of various tautomeric forms of the fluorine-containing s-triazino[1,2-a]benzimidazole compounds. The synthesized compounds were also screened for antibacterial and bovine dihydrofolate reductase (DHFR) inhibitory activities. The compound 3g substituted with a 3',5-bis(trifluoromethyl)phenyl moiety demonstrated the best antibacterial activity in the series. None of the tested compounds significantly inhibited bovine DHFR. (c) 2005 Elsevier B.V. All rights reserved.
  • Synthesis, crystal structure determination and antiproliferative activity of novel 2-amino-4-aryl-4,10-dihydro[1,3,5]triazino[1,2-a]benzimidazoles
    作者:Marijana Hranjec、Gordana Pavlović、Grace Karminski-Zamola
    DOI:10.1016/j.molstruc.2011.10.054
    日期:2012.1
    molecular structure of 4f was determined by X-ray diffraction on single crystals. The molecule of 2-amino-4-(4′-methylphenyl)-4,10-dihydro[1,3,5]triazino[1,2- a ]benzimidazole hydrochloride 4f (C 16 H 16 N 5 + ·Cl − ) exists in the solid state in one of the possible tautomeric forms, being protonated at the one of the nitrogen atoms of the 1,4-dihydrotriazine ring. The molecule is highly delocalized within
    摘要 本手稿描述了新型 2-氨基-4-芳基-4,10-二氢-[1,3,5] 三嗪基[1,2-a]苯并咪唑盐酸盐 4a-n 和 5b 的合成2-胍基苯并咪唑与多功能杂芳醛之间的环缩合反应。已通过使用 1 H 和 13 C NMR、IR 和 UV/Vis 光谱研究了所有制备的化合物的结构。4f 的晶体和分子结构是通过单晶的 X 射线衍射确定的。2-氨基-4-(4'-甲基苯基)-4,10-二氢[1,3,5]三嗪基[1,2-a]苯并咪唑盐酸盐4f(C 16 H 16 N 5 + ·Cl - ) 以一种可能的互变异构形式以固态存在,在 1,4-二氢三嗪环的一个氮原子上被质子化。该分子在 4,10-二氢 [1,3,5] 三嗪基 [1, 2-a ]苯并咪唑部分与次甲基碳原子和 1,4-二氢三嗪环的质子化氮原子的平面偏差最大。阳离子通过 N–H⋯N 氢键连接成 R 2 2 (8) 中心对称二聚体。阳离子二聚体通过
查看更多